Proteomic Analysis Identifies Novel Plasma Biomarkers in Patients With Vestibular Schwannoma
Proteomic analysis of VS patient plasma identified several disease-classifying biomarkers. Hepcidin warrants further investigation into its role in VS progression.
Authors
- G Giordano (ORCID: https://orcid.org/0000-0003-0177-4430)
- Han T. N. Nguyen
- Hsuan-Chih Kuo (ORCID: https://orcid.org/0000-0001-8062-3053)
- Saša Vasilijić (ORCID: https://orcid.org/0000-0002-3923-3448)
- Towia Aron Libermann (ORCID: https://orcid.org/0000-0002-4006-8179)
- Konstantina M. Stanković (ORCID: https://orcid.org/0000-0003-0233-279X)
- Yin Ren (ORCID: https://orcid.org/0000-0002-3865-0012)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Palo Alto University (US)
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Otology & Neurotology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1097/mao.0000000000004729
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00